Refurbished Medical Devices: Transforming India’s Healthcare Landscape with Safe and Affordable Solutions
In the pursuit of accessible and cost-effective healthcare, refurbished medical devices have emerged as a pivotal component in India's medical infrastructure. By providing high-quality equipment at reduced costs, these devices are instrumental in bridging the

In the pursuit of accessible and cost-effective healthcare, refurbished medical devices have emerged as a pivotal component in India’s medical infrastructure. By providing high-quality equipment at reduced costs, these devices are instrumental in bridging the healthcare gap, particularly in underserved regions.
The Role of Refurbished Medical Devices in India
Refurbished medical devices are pre-owned equipment restored to their original specifications, ensuring safety and efficacy. This process involves rigorous testing, replacement of worn parts, and adherence to stringent quality standards. The adoption of such devices offers several advantages:
Cost-Effectiveness: Refurbished equipment is typically 30–70% less expensive than new devices, enabling healthcare providers, especially in tier II and III cities, to access advanced technology without significant financial strain.
Enhanced Accessibility: Affordable medical devices facilitate the establishment and expansion of healthcare services in rural and underserved areas, improving patient access to essential diagnostics and treatments.
Environmental Sustainability: By extending the lifecycle of medical equipment, refurbishment reduces electronic waste, aligning with global sustainability goals and India’s commitment to environmental conservation.
Current Market Landscape
The refurbished medical equipment sector constitutes approximately 10% of India’s total medical equipment industry. This segment plays a vital role in meeting the healthcare demands of a vast and diverse population.
Regulatory Developments
In January 2025, the Central Drugs Standard Control Organisation (CDSCO) suspended all imports of refurbished medical devices until the Ministry of Health and Family Welfare (MoHFW) establishes a comprehensive policy framework. This decision has elicited varied responses from industry stakeholders.
Pavan Choudary, Chairman of the Medical Technology Association of India (MTaI), emphasized the significance of refurbished devices in expanding healthcare access. He stated, “If a swiftly implementable policy is not introduced soon, it could lead to irreversible damage to both healthcare providers and the workforce.”
Conversely, Rajiv Nath, Forum Coordinator of the Association of Indian Medical Device Industry (AiMeD), supported the suspension, highlighting concerns about patient safety and the need for a robust regulatory framework. He remarked, “Until there is an unequivocal policy decision by MoHFW permitting imports of pre-owned equipment… it is not permissible to import pre-owned medical equipment.”
The Path Forward
The suspension of imports underscores the necessity for a well-defined policy governing refurbished medical devices. Such a framework should balance the imperative of patient safety with the benefits of cost-effective healthcare solutions. Key considerations include:
Establishing Quality Standards: Implementing stringent refurbishment protocols to ensure devices meet international safety and performance benchmarks.
Regulatory Oversight: Designating a dedicated authority to oversee the import, refurbishment, and distribution of pre-owned medical equipment, ensuring compliance with established standards.
Stakeholder Collaboration: Engaging industry experts, healthcare providers, and policymakers in the formulation of regulations that address economic and health considerations.
Conclusion
Refurbished medical devices represent a viable solution to enhance the affordability and accessibility of healthcare in India. The development and implementation of a comprehensive policy framework are crucial to harnessing their full potential while safeguarding patient well-being. Collaborative efforts between government bodies and industry stakeholders will be instrumental in shaping a sustainable and inclusive healthcare ecosystem.